SCAI Produces Consensus On Intra-Coronary Diagnostic Tools
This article was originally published in The Gray Sheet
Executive Summary
A group of experts convened by the Society for Cardiovascular Angiography and Interventions has produced recommendations for the optimal clinical application of three underutilized intra-coronary diagnostics – fractional flow reserve, intravascular ultrasound and optical coherence tomography – to improve patient care, especially in patients with complex heart disease or coronary lesions difficult to assess with standard angiography.
You may also be interested in...
TCT Conference In Brief
Clinical data news from the Transcatheter Cardiovascular Therapeutics conference held last week in Miami.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.